Skip to main content

Table 1 Clinical, demographic, and laboratory data

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Variables Healthy individuals (N = 30)
Values, mean ± SD or n/N (%)
Patients on HD (N = 78)
Values, mean ± SD or n/N (%)
Age (years) 48.3 ± 8.15 69.9 ± 10.7
Sex (female) 19/30 (63.3%) 34/78 (43.6%)
Body mass index (kg/m2) 22.2 ± 3.30 22.8 ± 4.69
Diabetes mellitus 0/30 (0%) 32/78 (41.0%)
Hemoglobin (g/dL) 14.0 ± 1.43 10.9 ± 1.28
Albumin (g/dL) 4.56 ± 0.263 3.62 ± 0.356
Aspartate aminotransferase (IU/L) 23.5 ± 9.78 14.2 ± 7.26
Alanine aminotransferase (IU/L) 21.5 ± 10.3 12.0 ± 6.74
Urea nitrogen (mg/dL) 13.0 ± 3.32 65.4 ± 15.9
Creatinine (mg/dL) 0.726 ± 0.157 10.6 ± 2.97
Uric acid (mg/dL) 5.01 ± 1.40 6.05 ± 1.42
Corrected calcium (mg/dL)a 9.35 ± 0.316 9.09 ± 0.568
Inorganic phosphorus (mg/dL) 3.35 ± 0.366 5.22 ± 1.48
Iron (μg/dL) 99.6 ± 33.8 69.8 ± 27.9
C-reactive protein (mg/dL) 0.0267 ± 0.0645 0.281 ± 0.671
  1. aCorrected calcium: total serum calcium corrected for serum albumin. HD, hemodialysis